Foghorn Therapeutics Inc.: Form 10-Q for the period ended Mar 31, 2021
Filed with the SEC on May 11, 2021 and accepted by EDGAR at May 11, 2021, 16:05 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2021-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2021-01-01 to 2021-03-31 | $286.0k | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Research and development | 3 months2021-01-01 to 2021-03-31 | $18.7m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2021-01-01 to 2021-03-31 | −$23.1m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2021-01-01 to 2021-03-31 | $486.0k | us-gaap:InterestExpense |
| Net income | 3 months2021-01-01 to 2021-03-31 | −$23.0m | us-gaap:NetIncomeLoss |
| Operating cash flow | 3 months2021-01-01 to 2021-03-31 | −$23.1m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2021-01-01 to 2021-03-31 | $1.8m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2021-03-31 | $66.4m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2021-03-31 | $165.3m | us-gaap:AssetsCurrent |
| Total assets | At period end2021-03-31 | $229.9m | us-gaap:Assets |
| Current liabilities | At period end2021-03-31 | $16.3m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2021-03-31 | $104.7m | us-gaap:Liabilities |
| Long-term debt | At period end2021-03-31 | $20.0m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2021-03-31 | $0 | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2021-03-31 | $125.2m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001628280-21-009813. Last ingested by Listed: Nov 9, 2026, 17:27 ET. Listed shows no prices and gives no investment advice.